Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Evogene Ltd. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 14 | 15 | +1 |
| Shares | 552.5K | 401.9K | −150.6K (−27.3%) |
| Value | $1.70M | $751.6K | −$944.4K (−55.7%) |
New holders (5)
Institutions that held Evogene Ltd. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 21,345 | $39.9K | 0.00% |
| Citadel Advisors LLC | 15,891 | $29.7K | 0.00% |
| Two Sigma Securities, LLC | 11,159 | $20.9K | 0.00% |
| SBI Securities Co., Ltd. | 72 | $135 | 0.00% |
| Synergy Financial Management, LLC | 20 | $61 | 0.00% |
Sold out (4)
Institutions that held Evogene Ltd. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Silverarc Capital Management, LLC | 307,974 | $945.5K |
| Renaissance Investment Group LLC | 10,000 | $30.7K |
| The PNC Financial Services Group, Inc. | 3,803 | $11.7K |
| Tower Research Capital LLC (TRC) | 290 | $890 |